If North Texas runs out of ICU hospital beds, doctors can consider a patient’s vaccination status
North Texas doctors have quietly developed a plan that seeks to prepare for the possibility that due to the COVID-19 surge the region will run out of intensive-care...
If the FDA approves Biogen’s Alzheimer’s treatment, I won’t prescribe it
From Jason Karlawish in STAT: Most visits to the memory center where I care for individuals living with Alzheimer’s disease end in disappointment. “Are there any new...
Imagining the Next Decade of Behavioral Science
Behavioral Scientist put together a collection of ideas about what the next decade of behavioral science will tackle. The online magazine called for “hopes, fears,...
Immunotherapy and Chemotherapy Use in Patients with Metastatic Bladder Cancer
In this conversation, Ronac Mamtani and Ravi Parikh join Alicia Morgans to discuss their recent work on bladder cancer outcomes and effectiveness research. They discuss...
Immunotherapy Use Increased in Patients Ineligible for Cancer Trials, Highlighting the Need for More Research in Vulnerable Populations
Ravi Parikh spoke to CURE about his recent study in JAMA Oncology, which explored the higher rate of immunotherapies used in trial-ineligible patients compared to...
Implementing Regulatory Broad Consent Under the Revised Common Rule: Clarifying Key Points and the Need for Evidence
Although it is not yet clear how broad consent will be perceived by those to whom it is offered, it is essential that it be contextualized in such a way that individuals...